Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1990 Oct;43(10):847–849. doi: 10.1136/jcp.43.10.847

Value of monoclonal anti-myeloperoxidase (MPO7) for diagnosing acute leukaemia.

J Storr 1, G Dolan 1, E Coustan-Smith 1, D Barnett 1, J T Reilly 1
PMCID: PMC502837  PMID: 1977771

Abstract

The expression of myeloperoxidase (MPO) was studied in 100 cases of acute leukaemia (83 with acute myeloid leukaemia (AML) and 17 acute lymphoblastic leukaemia (ALL) by both a conventional cytochemical method and the immunocytochemical antiperoxidase (APAAP) technique using the monoclonal antibody MPO7. In each case the staining was evaluated by light microscopical examination (percentage of positive cells). Of the 83 cases of AML, 78 (93.9%) were positive for MPO7 compared with 70 (84.3%) by cytochemistry. Antibodies against the myeloid markers CD13 and CD33 were positive in 71 (85.5%) and 70 (84.3%) cases, respectively. Importantly, all cases of ALL were negative for both MPO7 and cytochemical MPO staining even when they were positive for CD13 and CD33. These results indicate that the anti-myeloperoxidase antibody MPO7 is the most sensitive and specific reagent for the diagnosis of AML and should therefore be included in routine immunophenotyping panels.

Full text

PDF
847

Images in this article

848Image
on p.848

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bainton D. F., Ullyot J. L., Farquhar M. G. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med. 1971 Oct 1;134(4):907–934. doi: 10.1084/jem.134.4.907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  3. Bradstock K. F., Kirk J., Grimsley P. G., Kabral A., Hughes W. G. Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations. Br J Haematol. 1989 Aug;72(4):512–518. doi: 10.1111/j.1365-2141.1989.tb04315.x. [DOI] [PubMed] [Google Scholar]
  4. Chang K. S., Trujillo J. M., Cook R. G., Stass S. A. Human myeloperoxidase gene: molecular cloning and expression in leukemic cells. Blood. 1986 Dec;68(6):1411–1414. [PubMed] [Google Scholar]
  5. Davey F. R., Erber W. N., Gatter K. C., Mason D. Y. Immunophenotyping of acute myeloid leukemia by immuno-alkaline phosphatase (APAAP) labeling with a panel of antibodies. Am J Hematol. 1987 Oct;26(2):157–166. doi: 10.1002/ajh.2830260206. [DOI] [PubMed] [Google Scholar]
  6. Drexler H. G. Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. Leukemia. 1987 Oct;1(10):697–705. [PubMed] [Google Scholar]
  7. Ferrari S., Mariano M. T., Tagliafico E., Sarti M., Ceccherelli G., Selleri L., Merli F., Narni F., Donelli A., Torelli G. Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. Blood. 1988 Sep;72(3):873–876. [PubMed] [Google Scholar]
  8. Hanker J. S., Ambrose W. W., James C. J., Mandelkorn J., Yates P. E., Gall S. A., Bossen E. H., Fay J. W., Laszlo J., Moore J. O. Facilitated light microscopic cytochemical diagnosis of acute myelogenous leukemia. Cancer Res. 1979 May;39(5):1635–1639. [PubMed] [Google Scholar]
  9. Jani P., Verbi W., Greaves M. F., Bevan D., Bollum F. Terminal deoxynucleotidyl transferase in acute myeloid leukaemia. Leuk Res. 1983;7(1):17–29. doi: 10.1016/0145-2126(83)90054-1. [DOI] [PubMed] [Google Scholar]
  10. Koeffler H. P., Ranyard J., Pertcheck M. Myeloperoxidase: its structure and expression during myeloid differentiation. Blood. 1985 Feb;65(2):484–491. [PubMed] [Google Scholar]
  11. Laycock B. J., Britton J. A., Lilleyman J. S. A technique avoiding carcinogens for the demonstration of myeloperoxidase in blood and bone marrow smears. J Clin Pathol. 1980 Feb;33(2):194–196. doi: 10.1136/jcp.33.2.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Morishita Y., Morishima Y., Ogura M., Nagai Y., Ohno R. Biochemical characterization of human myeloperoxidase using three specific monoclonal antibodies. Br J Haematol. 1986 Jul;63(3):435–444. doi: 10.1111/j.1365-2141.1986.tb07520.x. [DOI] [PubMed] [Google Scholar]
  13. Osterholm M. T., Pierson L. M., White K. E., Libby T. A., Kuritsky J. N., McCullough J. G. The risk of subsequent transmission of Hemophilus influenzae type B disease among children in day care. Results of a two-year statewide prospective surveillance and contact survey. N Engl J Med. 1987 Jan 1;316(1):1–5. doi: 10.1056/NEJM198701013160101. [DOI] [PubMed] [Google Scholar]
  14. Pombo de Oliveira M. S., Matutes E., Rani S., Morilla R., Catovsky D. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia. Acta Haematol. 1988;80(2):61–64. doi: 10.1159/000205603. [DOI] [PubMed] [Google Scholar]
  15. van der Schoot C. E., Daams G. M., Pinkster J., Vet R., von dem Borne A. E. Monoclonal antibodies against myeloperoxidase are valuable immunological reagents for the diagnosis of acute myeloid leukaemia. Br J Haematol. 1990 Feb;74(2):173–178. doi: 10.1111/j.1365-2141.1990.tb02562.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES